Health
New study charts the complexity of SARS-CoV-2 neutralization – EurekAlert
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains…
Washington, DC – February 24, 2021 – In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus. But not every type of antibody can neutralize the virus and render it noninfectious. New research published this week in mSphere, an open-access journal of the American Society for Microbiology, explores variation in virus neutralization capabilities, which can vary…
-
General20 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General18 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured
-
General24 hours agoSydney men jailed over bucks party gang rape in Newcastle argue guilty verdicts ‘unsafe’